Background*

Dr. Robert A. Weinberg, also known as Bob, PhD. Co-Founded Theracrine, Inc. in 2010. Dr. Weinberg is Co-Founder of Verastem, Inc. and serves as its Chair of Scientific Advisory Board and served as its Co-Chair of Scientific Advisory Board. He has been a Member of Scientific Advisory Board at Syros Pharmaceuticals since April 2013. He serves as a Member of the Scientific Advisory Board at Astex Pharmaceuticals, Inc. Dr. Weinberg serves as a Member of the Scientific Advisory ... Board of SuperGen Inc., Asterand Bioscience, Inc. and Arqule Inc. He has been a Member of the Scientific Advisory Board at Cornerstone Pharmaceuticals Inc. since October 2009. He serves as a Member of the Scientific Advisory Board at Minerva Biotechnologies Corporation. has been an American Cancer Society Research Professor at Whitehead and MIT since 1985. He is a Founding Member of Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research in the Department of Biology at MIT. He joined the MIT faculty as a professor of biology in 1982. He is world renown for his expertise and vision in the basic understanding of the mechanisms that underlie cancers. He serves as a First Director of the Ludwig Cancer Center at MIT. He served on scientific advisory boards for the Institute of Molecular Pathology in Vienna, Austria and the Massachusetts General Hospital in Boston. Dr. Weinberg is the Author or Editor of five books and more than 350 articles. He has published a textbook "The Biology of Cancer". He is an elected Member of the U.S. National Academy of Sciences and the Institute of Medicine and is a Fellow of the American Academy of Arts and Sciences. Among his honors are the Discover Magazine 1982 Scientist of the Year, the National Academy of Sciences/U.S. Steel Foundation Award in Molecular Biology, the Sloan Prize of the General Motors Cancer Research Foundation, the Bristol-Myers Award for Distinguished Achievement in Cancer Research, the Landon Prize of the American Association for Cancer Research, the Gairdner Foundation International Award, the Keio Medical Foundation Prize, 1997 National Medal of Science and the Otto Warburg Medal in 2007. He published the landmark paper "Mechanism of Activation of a Human Oncogene" in the journal Nature. In 1999, he published "Creation of Human Tumor Cells with Defined Genetic Elements" also in Nature. He did Postdoctoral Research at the Weizmann Institute in Rehovoth, Israel and the Salk Institute in La Jolla, California, and then returned to MIT in 1972. He received a B.S. in 1964 and Ph.D. in 1969 in Biology from MIT.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.